NCT03407716 - Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

May 13, 2020

Study Completion Date

February 22, 2021

Conditions

Cancer SurvivorStage I Breast Cancer AJCC v7Stage I Colon Cancer AJCC v6 and v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7Stage II Breast Cancer AJCC v6 and v7Stage II Colon Cancer AJCC v7Stage IIA Breast Cancer AJCC v6 and v7Stage IIA Colon Cancer AJCC v7Stage IIB Breast Cancer AJCC v6 and v7Stage IIB Colon Cancer AJCC v7Stage IIC Colon Cancer AJCC v7Stage III Breast Cancer AJCC v7Stage III Colon Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7Stage IIIA Colon Cancer AJCC v7Stage IIIB Breast Cancer AJCC v7Stage IIIB Colon Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7Stage IIIC Colon Cancer AJCC v7

Interventions

DRUG

American Ginseng

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Placebo

Given PO

OTHER

Questionnaire Administration

Correlative studies

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale